ARTICLE | Company News
Chiron news
April 3, 1995 7:00 AM UTC
Chiron Corp. (CHIR) CHIR will scale back excess manufacturing capacity for Betaseron (interferon beta-1b) as a result of lackluster demand for the multiple sclerosis treatment. The Emeryville, Calif....